Beam Diagnostics and Excella agreed to work together to develop an application that will help in detecting relapse in patients with alcohol use disorder and in helping clinicians predict when patients may be at risk of relapse.
Excella, Beam to create app for alcohol use disorder relapse
Sign up for FDLI SmartBrief
News for the food and drug law community
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.